Medtronic Diabetes

Medtronic Diabetes is a leading provider of advanced diabetes management technologies designed to help people with insulin-requiring diabetes and care teams optimize glucose control and therapy adherence. The platform combines continuous glucose monitoring (CGM), insulin pump systems, and smart insulin delivery solutions to support real-time decision-making and personalized treatment. Medtronic’s portfolio includes automated insulin delivery systems with adaptive algorithms that adjust basal and bolus dosing based on glucose trends, as well as integrated software tools for therapy management and reporting. Healthcare professionals benefit from configurable clinical settings, seamless interoperability with monitoring devices, and educational resources that support improved outcomes across care settings. With decades of innovation in diabetes care, Medtronic continues to develop solutions that streamline daily management, reduce variability in glycemic control, and enhance the quality of life for people living with diabetes.

Medtronic Diabetes belongs to the Diabetes Management, Insulin Management, Glycemic Management, Glycemic Intelligence Platform category.

Medtronic Diabetes is used in industries such as Health, Hospital & Health Care.

Medtronic Diabetes is built for Small Business, Mid Size Business

Medtronic Diabetes supports English

Medtronic Diabetes supports Windows, Web-based devices.

No, Medtronic Diabetes does not offer a free trial.

Medtronic Diabetes has approximately 11-50 employees.

Medtronic Diabetes is located in United States.

Medtronic Diabetes was founded by Medtronic Diabetes.